Physician profile
Andrea E Deneen
NPI 1679679781
$4,136.49
in general payments reported to CMS, 2019-2025
17 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $249 · 2021: $616 · 2022: $711 · 2023: $878 · 2024: $637 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,039.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,710.41 | 2019-2024 | Impella |
| Boston Scientific Corporation | $448.10 | 2023-2024 | Watchman Flx |
| Medtronic, INC. | $427.61 | 2021-2023 | Cobalt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $341.06 | 2019-2025 | Triclip, Gallant, Mitraclip |
| Astrazeneca Pharmaceuticals Lp | $245.68 | 2019-2025 | Farxiga |
| Edwards Lifesciences Corporation | $136.91 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $115.46 | 2025 | Camzyos |
| Pfizer INC. | $114.09 | 2022 | |
| United Therapeutics Corporation | $108.38 | 2025 | |
| Cvrx, INC. | $102.31 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.59 | 2022-2025 | Lifevest |
| Biosense Webster, INC. | $79.51 | 2024 | Carto 3 |
| Lantheus Medical Imaging, INC. | $79.40 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $74.54 | 2020-2025 | Uptravi, Opsynvi |
| Inspire Medical Systems, INC. | $25.64 | 2024 | Inspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.19 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $20.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Deneen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.